Literature DB >> 17492595

Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.

Laura Gibson1, Sheryl Dooley, Sonia Trzmielina, Mohan Somasundaran, Donna Fisher, Maria Grazia Revello, Katherine Luzuriaga.   

Abstract

Cytomegalovirus (CMV) infection remains a significant cause of morbidity and mortality in young children. We have previously shown that CD8+ T cell responses to CMV pp65 or IE1 protein were readily detectable in children with congenital or postnatal CMV infection. Here, we have further characterized the evolution of the peptide specificity of these responses in 7 infants<6 months of age at the start of the study. Thirteen pp65 and 15 IE1 peptides (median, 5 peptides/infant) were targeted, and most (61%) represented sequences not previously reported. Peptide specificity remained stable or broadened over time despite the clearance of CMV viremia. Loss of peptide recognition was not observed. Responses with the highest functional peptide avidity were not necessarily detected earliest. These data provide additional evidence that young infants can generate diverse CMV-specific CD8+ T cell responses but show that early responses may exhibit relatively focused peptide specificity and lower peptide avidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492595     DOI: 10.1086/518042

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections.

Authors:  Nicholas Renzette; Laura Gibson; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Curr Opin Virol       Date:  2014-08-25       Impact factor: 7.090

2.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

3.  Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.

Authors:  Sharon F Chen; Tyson H Holmes; Teri Slifer; Vasavi Ramachandran; Sally Mackey; Cathleen Hebson; Ann M Arvin; David B Lewis; Cornelia L Dekker
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09-11       Impact factor: 3.164

Review 4.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

5.  Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.

Authors:  Alda Saldan; Gabriella Forner; Carlo Mengoli; Daniel Tinto; Loredana Fallico; Marta Peracchi; Nadia Gussetti; Giorgio Palù; Davide Abate
Journal:  J Clin Microbiol       Date:  2016-03-09       Impact factor: 5.948

6.  Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Authors:  Laura Gibson; Constance M Barysauskas; Margaret McManus; Sheryl Dooley; Daniele Lilleri; Donna Fisher; Tumul Srivastava; Don J Diamond; Katherine Luzuriaga
Journal:  J Clin Immunol       Date:  2015-02-25       Impact factor: 8.317

7.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

Review 8.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

Review 10.  Interplay between human cytomegalovirus and dendritic cells in T cell activation.

Authors:  Hélène Martin; Marie Mandron; Christian Davrinche
Journal:  Med Microbiol Immunol       Date:  2008-02-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.